NVAX Novavax, Inc. Stock Quote

NVAX [NASD]

Index	-	P/E	-	EPS (ttm)	-14.82	Insider Own	0.30%	Shs Outstand	74.75M	Perf Week	14.09%
Market Cap	16.37B	Forward P/E	7.96	EPS next Y	27.40	Insider Trans	-63.80%	Shs Float	-	Perf Month	53.99%
Income	-1075.00M	PEG	-	EPS next Q	5.96	Inst Own	50.20%	Short Float	-	Perf Quarter	-3.84%
Sales	1.20B	P/S	13.60	EPS this Y	-32.00%	Inst Trans	-5.91%	Short Ratio	1.69	Perf Half Y	47.66%
Book/sh	6.17	P/B	35.33	EPS next Y	416.40%	ROA	-45.20%	Target Price	260.60	Perf Year	112.45%
Cash/sh	25.79	P/C	8.45	EPS next 5Y	0.00%	ROE	-149.70%	52W Range	94.67 - 331.68	Perf YTD	95.47%
Dividend	-	P/FCF	36.08	EPS past 5Y	9.50%	ROI	-38.00%	52W High	-34.28%	Beta	1.34
Dividend %	-	Quick Ratio	1.20	Sales past 5Y	67.30%	Gross Margin	-	52W Low	130.24%	ATR	14.58
Employees	791	Current Ratio	1.20	Sales Q/Q	13.90%	Oper. Margin	-86.80%	RSI (14)	66.63	Volatility	6.09% 7.32%
Optionable	Yes	Debt/Eq	0.93	EPS Q/Q	-34.60%	Profit Margin	-89.30%	Rel Volume	1.26	Prev Close	200.07
Shortable	Yes	LT Debt/Eq	0.70	Earnings	Nov 04 AMC	Payout	-	Avg Volume	4.89M	Price	217.97
Recom	2.20	SMA20	22.25%	SMA50	20.04%	SMA200	10.17%	Volume	6,145,777	Change	8.95%

May-12-21

Downgrade

JP Morgan

Overweight → Neutral

$285 → $161

Dec-14-20

Initiated

Jefferies

Buy

$200

Aug-06-20

Reiterated

H.C. Wainwright

Buy

$132 → $290

Aug-05-20

Upgrade

JP Morgan

Neutral → Overweight

$275

Aug-05-20

Downgrade

Ladenburg Thalmann

Neutral → Sell

$105

Jul-16-20

Reiterated

H.C. Wainwright

Buy

$101 → $132

Jul-08-20

Downgrade

Ladenburg Thalmann

Buy → Neutral

$50 → $105

Jun-29-20

Reiterated

H.C. Wainwright

Buy

$50 → $101

Jun-29-20

Reiterated

B. Riley FBR

Buy

$74 → $106

Jun-05-20

Upgrade

JP Morgan

Underweight → Neutral

$46

May-28-20

Reiterated

B. Riley FBR

Buy

$53 → $61

May-12-20

Reiterated

H.C. Wainwright

Buy

$33 → $50

Apr-30-20

Reiterated

H.C. Wainwright

Buy

$24 → $33

Nov-27-19

Resumed

B. Riley FBR

Buy

$12

Aug-14-19

Reiterated

H.C. Wainwright

Buy

$10 → $17

Feb-28-19

Downgrade

Piper Jaffray

Overweight → Underweight

$4.50 → $0.25

Dec-18-18

Initiated

Ladenburg Thalmann

Buy

Dec-11-18

Initiated

Oppenheimer

Outperform

Nov-26-18

Upgrade

Piper Jaffray

Neutral → Overweight

Sep-21-18

Upgrade

JP Morgan

Underweight → Overweight

Nov-28-21 06:59PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment Novavax, Inc. of Class Action Lawsuit and Upcoming Deadline - NVAX Newsfile
02:38PM	NVAX LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Novavax, Inc. Newsfile
11:45AM	SHAREHOLDER ACTION REMNINDER: The Schall Law Firm Encourages Investors in Novavax, Inc. with Losses of $100,000 to Contact the Firm ACCESSWIRE
10:30AM	Moderna, Pfizer, and Novavax Are Must-Own Stocks This Week Motley Fool
Nov-27-21 10:15PM	NVAX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of January 11, 2022 in the Class Action Filed on Behalf of Novavax, Inc. Limited Shareholders Newsfile
07:22PM	INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Alerts Novavax, Inc. (NVAX) Shareholders of Securities Fraud Class Action Lawsuit on Their Behalf Newsfile
01:30PM	SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Novavax, Inc. with Losses of $100,000 to Contact the Firm ACCESSWIRE
09:03AM	NVAX ALERT: Investors with Substantial Losses Have Opportunity to Lead the Novavax, Inc. Class Action Lawsuit Business Wire
Nov-26-21 10:50PM	INVESTOR ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Class Action Lawsuits filed on behalf of EAR, NVAX, ONTF, Z Investors, Lead Plaintiff Deadlines Set GlobeNewswire +8.95%
06:04PM	UPDATE 1-Novavax developing vaccine that targets new COVID-19 variant Reuters
02:41PM	Novavax testing vaccine that targets new COVID-19 variant Reuters
01:44PM	NVAX LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Novavax, Inc. Newsfile
01:32PM	What the newly discovered COVID-19 variants means for investors: Stifel chief equity strategist Yahoo Finance Video
12:00PM	NVAX INVESTOR ALERT: Shareholder Lawsuit Filed ACCESSWIRE
11:40AM	Vaccines 'still the backbone of everything we do' amid any variants, doctor explains Yahoo Finance Video
11:00AM	SBTX, TWVLX & NVAX - Bronstein, Gewirtz & Grossman, LLC Alerts Shareholders of Class Action Deadlines ACCESSWIRE
10:53AM	Market selloff: COVID-19 news 'caught people by surprise' on shortened day, strategist explains Yahoo Finance Video
10:40AM	Stocks fall, Merck drops on COVID-19 pill effectiveness, air travel hits pandemic high, more PPP fraud Yahoo Finance Video
10:25AM	NVAX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of January 11, 2022 in the Class Action Filed on Behalf of Novavax, Inc. Limited Shareholders Newsfile
10:03AM	Important Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Novavax, Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Significant Losses to Contact the Firm PR Newswire
09:42AM	Hospital capacity is key for COVID-19 containment going forward: Oppenheimer analyst Yahoo Finance Video
09:30AM	'Travel bans don't work,' doctor explains amid reports of newly discovered variant Yahoo Finance Video
09:27AM	Market strategist details 'the critical issue' to understand about risk from new COVID-19 variant Yahoo Finance Video
09:17AM	Stocks down after discovery of new COVID-19 variant Yahoo Finance Video
05:35AM	Vaccine Stocks Benefit From Covid-19 Variant Concerns Investing.com
Nov-25-21 11:42PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment Novavax, Inc. of Class Action Lawsuit and Upcoming Deadline - NVAX PR Newswire
11:10PM	SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS CTXS, HMLP, NVAX INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits ACCESSWIRE
07:00PM	ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Novavax, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action NVAX GlobeNewswire
08:50AM	Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for Novavax, Inc. Investors GlobeNewswire
07:35AM	15 Pharmaceutical Stocks to Buy According to Peter Kolchinskys RA Capital Insider Monkey
Nov-24-21 11:33PM	SHAREHOLDER ALERT: CLAIMSFILER REMINDS HYZN, NVAX, ONTF INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
05:07PM	NOVAVAX SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Novavax, Inc. - NVAX PR Newswire
04:55PM	COVID-19: Vaccines absolutely decrease the risk of transmission, doctor says Yahoo Finance Video
02:37PM	Why Novavax Was Wilting on Wednesday Motley Fool
12:27PM	DEADLINE ALERT for ONTF, SNAP, and NVAX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
11:17AM	EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Novavax, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action NVAX Business Wire
11:00AM	Germany mulls a lockdown as COVID cases rise in Europe Yahoo Finance Video
08:30AM	Novavax Files for Interim Authorization of COVID-19 Vaccine in Singapore PR Newswire
07:00AM	Better Buy: Ocugen or Novavax? Motley Fool
06:25AM	2 Top Biotech Stocks Ready for a Bull Run Motley Fool
12:04AM	FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of EAR, NVAX and ONTF GlobeNewswire
Nov-23-21 06:16PM	SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Novavax, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm PR Newswire
04:30PM	COVID-19 vaccines have proved their merit at this point: Doctor Yahoo Finance Video
01:12PM	Ones To Watch: Novavax Stock Sees RS Rating Jump To 85 Investor's Business Daily
12:00PM	DEADLINE ALERT for ONTF, SNAP, NVAX, Z/ZG: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
11:55AM	Countries pushing vaccine IP waivers want to take advantage of the technology: Fmr. U.S. Commerce Secretary Yahoo Finance Video
11:50AM	Is Novavax Stock A Buy Now That European Officials Are Reviewing Its Covid Shot? Investor's Business Daily
10:26AM	COVID-19: The U.S. issues advisory for travel to Europe but has no plans for a lockdown Yahoo Finance Video
09:15AM	Novavax to Participate in Evercore ISI's 4th Annual HealthCONx Virtual Conference PR Newswire
Nov-22-21 10:39PM	SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS EAR, NVAX, ONTF, Z INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire +8.14%
10:30PM	NOVAVAX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Novavax, Inc. and Encourages Investors to Contact the Firm GlobeNewswire
06:19PM	Novavax: Covid-19 Vaccine Gathering Momentum TipRanks
04:20PM	One dose of the J&J COVID-19 vaccine is certainly not enough: Doctor Yahoo Finance Video
04:00PM	LAWSUIT FILED Novavax Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information GlobeNewswire
03:45PM	NOVAVAX, INC. (NASDAQ: NVAX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Novavax, Inc. ACCESSWIRE
02:46PM	NVAX LAWSUIT: Hagens Berman, National Trial Attorneys, Encourages Novavax (NVAX) Investors with Significant Losses to Contact Firms Attorneys Now, Securities Class Action Pending GlobeNewswire
02:29PM	SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Novavax, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
02:10PM	NVAX Investor Alert: Shareholder Lawsuit Filed Newsfile
01:30PM	BMY, HMLP, NVAX SHAREHOLDERS - ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Class Action lawsuits filed on behalf of Investors, Lead Plaintiff Deadlines Set ACCESSWIRE
01:29PM	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Novavax, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 11, 2022 - (NVAX) Newsfile
11:30AM	Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Novavax, Inc. (NVAX) Business Wire
11:15AM	NVAX LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Novavax, Inc. Newsfile
11:00AM	NVAX Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Novavax, Inc. Shareholders of Class Action and Lead Deadline: January 11, 2022 Business Wire
10:21AM	COVID-19 cases and hospitalizations on the rise ahead of holiday gatherings Yahoo Finance Video
09:41AM	NVAX DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Novavax, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit GlobeNewswire
08:50AM	INVESTOR ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Novavax, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
05:28AM	NVAX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of January 11, 2022 in the Class Action Filed on Behalf of Novavax, Inc. Limited Shareholders Newsfile
Nov-21-21 10:45PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment Novavax, Inc. of Class Action Lawsuit and Upcoming Deadline NVAX ACCESSWIRE
06:15PM	Important January 11, 2022 Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Novavax, Inc. Investors of Securities Fraud Class Action Lawsuit Newsfile
06:30AM	Will Novavax Be Worth as Much as Moderna by 2025? Motley Fool
Nov-20-21 09:36PM	NVAX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of January 11, 2022 in the Class Action Filed on Behalf of Novavax, Inc. Limited Shareholders Newsfile
06:13PM	NVAX ALERT: Novavax, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit PR Newswire
Nov-19-21 10:00PM	HYZN, NVAX, ONTF INVESTOR ALERT BY CLAIMSFILER: Pending Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
09:44PM	Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Novavax, Inc. - NVAX PR Newswire
06:00PM	What Are the Top COVID Plays for 2022? Motley Fool
02:59PM	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Novavax, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 11, 2022 - (NVAX) Newsfile
02:53PM	INVESTOR ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Novavax, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
01:30PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Novavax (NVAX) Investors to Filing of Securities Class Action, Encourages Investors with Significant Losses to Contact Firms Attorneys ACCESSWIRE
01:15PM	NOVAVAX, INC. (NASDAQ: NVAX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Novavax, Inc. GlobeNewswire
12:29PM	NVAX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of January 11, 2022 in the Class Action Filed on Behalf of Novavax, Inc. Limited Shareholders Newsfile
11:00AM	NVAX Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Novavax, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: January 11, 2022 ACCESSWIRE
10:45AM	NOVAVAX INVESTOR ALERT: Class Action Lawsuit Filed ACCESSWIRE
10:30AM	Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Novavax, Inc. (NVAX) Business Wire
10:00AM	LAWSUITS FILED AGAINST ZEV, Z and NVAX - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
09:30AM	INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Novavax, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
05:40AM	SHAREHOLDER ALERT: HMLP LSPD NVAX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
Nov-18-21 11:26PM	FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Novavax, Inc. - NVAX PR Newswire
10:05PM	NVAX ALERT: Robbins Geller Rudman & Dowd LLP Announces that Novavax, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit ACCESSWIRE
07:58PM	NVAX LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Novavax, Inc. Newsfile
06:28PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment Novavax, Inc. of Class Action Lawsuit and Upcoming Deadline NVAX GlobeNewswire
05:40PM	SHAREHOLDER ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Novavax Investors of Securities Fraud Class Action Lawsuit Filed On Their Behalf Business Wire
05:25PM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AMRN, FB and NVAX ACCESSWIRE
04:45PM	NVAX SECURITIES FRAUD: Hagens Berman, National Trial Attorneys, Encourages Novavax (NVAX) Investors with Significant Losses to Contact Firm's Attorneys Now, Securities Class Action Pending Newsfile
03:40PM	LAWSUITS FILED AGAINST CEI, LSPD And NVAX - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
03:16PM	UPDATE 1-India allows export of 20 mln Novavax vaccine doses to Indonesia -document, source Reuters
02:41PM	SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Novavax, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
02:26PM	India allows export of 20 mln Novavax vaccine doses to Indonesia -document, source Reuters
01:56PM	'Everyone is a little bit confused' about COVID-19 vaccine mandates and rules: Doctor Yahoo Finance Video
12:58PM	Novavax (NVAX) COVID Jab Gets Philippines Nod, Under Review in EU Zacks
12:20PM	FDA reviews mRNA booster shots for all adults ahead of holiday travel Yahoo Finance Video

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. In addition, the company develops vaccine candidates for the protection against middle east respiratory syndrome, as well as that is in preclinical work associated with severe acute respiratory syndrome; and ebola virus glycoprotein vaccine candidate, as well as COVID-19 vaccine for variant strain. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Glenn Gregory M	President, R&D	Nov 23	Option Exercise	19.08	8,250	157,410	12,311	Nov 24 05:21 PM
Glenn Gregory M	President, R&D	Nov 23	Sale	199.50	8,250	1,645,914	4,061	Nov 24 05:21 PM
Glenn Gregory M	President, R&D	Nov 16	Option Exercise	19.08	8,250	157,410	12,311	Nov 17 05:25 PM
Glenn Gregory M	President, R&D	Nov 16	Sale	169.48	8,250	1,398,180	4,061	Nov 17 05:25 PM
Glenn Gregory M	President, R&D	Nov 15	Option Exercise	37.90	1,183	44,832	5,244	Nov 17 05:25 PM
Glenn Gregory M	President, R&D	Nov 15	Sale	172.02	1,183	203,496	4,061	Nov 17 05:25 PM
Glenn Gregory M	President, R&D	Nov 09	Option Exercise	19.08	8,250	157,410	12,311	Nov 12 05:02 PM
Glenn Gregory M	President, R&D	Nov 09	Sale	167.53	8,250	1,382,160	4,061	Nov 12 05:02 PM
Herrmann John A III	EVP, Chief Legal Officer	Nov 03	Option Exercise	19.08	5,000	95,400	7,760	Nov 05 05:02 PM
Herrmann John A III	EVP, Chief Legal Officer	Nov 03	Sale	200.00	5,000	1,000,000	2,760	Nov 05 05:02 PM
Glenn Gregory M	President, R&D	Nov 02	Option Exercise	19.08	8,250	157,410	12,311	Nov 04 05:22 PM
Glenn Gregory M	President, R&D	Nov 02	Sale	183.82	8,250	1,516,552	4,061	Nov 04 05:22 PM
Herrmann John A III	EVP, Chief Legal Officer	Nov 01	Option Exercise	19.08	5,000	95,400	7,760	Nov 03 04:49 PM
Herrmann John A III	EVP, Chief Legal Officer	Nov 01	Sale	163.08	5,000	815,422	2,760	Nov 03 04:49 PM
Glenn Gregory M	President, R&D	Oct 29	Sale	148.34	680	100,871	4,061	Nov 02 07:02 PM
Glenn Gregory M	President, R&D	Oct 26	Option Exercise	15.20	11,712	178,009	14,395	Oct 28 05:09 PM
Glenn Gregory M	President, R&D	Oct 26	Sale	132.73	10,334	1,371,667	4,061	Oct 28 05:09 PM
Glenn Gregory M	President, R&D	Oct 19	Option Exercise	19.08	8,250	157,410	12,311	Oct 21 05:08 PM
Glenn Gregory M	President, R&D	Oct 19	Sale	165.14	8,250	1,362,427	4,061	Oct 21 05:08 PM
Glenn Gregory M	President, R&D	Oct 15	Option Exercise	37.90	1,183	44,832	5,244	Oct 19 05:04 PM
Glenn Gregory M	President, R&D	Oct 15	Sale	170.00	1,183	201,110	4,061	Oct 19 05:04 PM
Glenn Gregory M	President, R&D	Oct 12	Option Exercise	19.08	8,250	157,410	12,311	Oct 14 05:16 PM
Glenn Gregory M	President, R&D	Oct 12	Sale	163.18	8,250	1,346,218	4,061	Oct 14 05:16 PM
Glenn Gregory M	President, R&D	Oct 05	Option Exercise	19.08	8,250	157,410	12,311	Oct 07 05:18 PM
Glenn Gregory M	President, R&D	Oct 05	Sale	174.41	8,250	1,438,895	4,061	Oct 07 05:18 PM
Erck Stanley C	President and CEO	Oct 04	Option Exercise	27.45	42,829	1,175,583	66,708	Oct 05 05:05 PM
Erck Stanley C	President and CEO	Oct 04	Sale	176.15	42,829	7,544,195	23,879	Oct 05 05:05 PM
Herrmann John A III	EVP, Chief Legal Officer	Oct 01	Option Exercise	19.08	5,000	95,400	7,760	Oct 05 05:02 PM
Erck Stanley C	President and CEO	Oct 01	Option Exercise	27.17	49,000	1,331,400	72,879	Oct 05 05:04 PM
Erck Stanley C	President and CEO	Oct 01	Sale	175.10	49,000	8,580,064	23,879	Oct 05 05:04 PM
Herrmann John A III	EVP, Chief Legal Officer	Oct 01	Sale	174.89	5,000	874,452	2,760	Oct 05 05:02 PM
Glenn Gregory M	President, R&D	Sep 30	Sale	207.25	693	143,622	4,061	Oct 01 05:58 PM
Trizzino John	EVP, CCO and CBO	Sep 28	Option Exercise	19.08	7,501	143,119	10,047	Sep 29 05:06 PM
Trizzino John	EVP, CCO and CBO	Sep 28	Sale	209.92	7,501	1,574,637	2,546	Sep 29 05:06 PM
Trizzino John	EVP, CCO and CBO	Sep 27	Option Exercise	19.08	7,501	143,119	10,047	Sep 29 05:04 PM
Glenn Gregory M	President, R&D	Sep 27	Option Exercise	5.95	3,460	20,587	6,144	Sep 29 05:08 PM
Glenn Gregory M	President, R&D	Sep 27	Sale	234.43	2,083	488,315	4,061	Sep 29 05:08 PM
Trizzino John	EVP, CCO and CBO	Sep 27	Sale	234.61	7,501	1,759,833	2,546	Sep 29 05:04 PM
MOTT DAVID M	Director	Sep 23	Sale	252.90	24,961	6,312,616	40,000	Sep 24 05:10 PM
Trizzino John	EVP, CCO and CBO	Sep 21	Option Exercise	19.08	7,500	143,100	8,218	Sep 22 05:05 PM
Trizzino John	EVP, CCO and CBO	Sep 21	Sale	227.37	7,500	1,705,265	718	Sep 22 05:05 PM
Trizzino John	EVP, CCO and CBO	Sep 20	Option Exercise	19.08	7,500	143,100	8,218	Sep 22 05:05 PM
Trizzino John	EVP, CCO and CBO	Sep 20	Sale	227.57	7,500	1,706,748	718	Sep 22 05:05 PM
Glenn Gregory M	President, R&D	Sep 15	Option Exercise	37.90	1,183	44,832	5,244	Sep 17 05:08 PM
Herrmann John A III	EVP, Chief Legal Officer	Sep 15	Option Exercise	19.08	5,000	95,400	5,706	Sep 17 05:11 PM
Herrmann John A III	EVP, Chief Legal Officer	Sep 15	Sale	229.44	5,000	1,147,193	706	Sep 17 05:11 PM
Glenn Gregory M	President, R&D	Sep 15	Sale	229.34	1,183	271,304	4,061	Sep 17 05:08 PM
Trizzino John	EVP, CCO and CBO	Sep 14	Option Exercise	19.08	7,499	143,081	8,217	Sep 15 05:03 PM
Trizzino John	EVP, CCO and CBO	Sep 14	Sale	236.61	7,499	1,774,360	718	Sep 15 05:03 PM
Trizzino John	EVP, CCO and CBO	Sep 13	Option Exercise	19.08	7,499	143,081	8,217	Sep 15 05:03 PM
Trizzino John	EVP, CCO and CBO	Sep 13	Sale	235.29	7,499	1,764,433	718	Sep 15 05:03 PM
Herrmann John A III	EVP, Chief Legal Officer	Sep 01	Option Exercise	19.08	5,000	95,400	5,706	Sep 03 05:10 PM
Herrmann John A III	EVP, Chief Legal Officer	Sep 01	Sale	247.97	5,000	1,239,867	706	Sep 03 05:10 PM
Glenn Gregory M	President, R&D	Aug 31	Sale	239.87	1,386	332,463	4,061	Sep 01 05:23 PM
Glenn Gregory M	President, R&D	Aug 26	Option Exercise	5.95	6,921	41,180	8,228	Aug 30 06:16 PM
Glenn Gregory M	President, R&D	Aug 26	Sale	233.92	4,167	974,740	4,061	Aug 30 06:16 PM
Glenn Gregory M	President, R&D	Aug 16	Option Exercise	40.64	1,866	75,826	5,927	Aug 18 05:26 PM
Glenn Gregory M	President, R&D	Aug 16	Sale	233.52	1,866	435,750	4,061	Aug 18 05:26 PM
Herrmann John A III	EVP, Chief Legal Officer	Jul 26	Option Exercise	14.83	2,896	42,960	3,602	Jul 28 05:00 PM
Herrmann John A III	EVP, Chief Legal Officer	Jul 26	Sale	197.74	2,896	572,648	706	Jul 28 05:00 PM
Glenn Gregory M	President, R&D	Jul 20	Sale	215.43	2,409	518,982	2,811	Jul 22 05:20 PM
Glenn Gregory M	President, R&D	Jul 15	Option Exercise	13.08	10,477	137,006	8,465	Jul 19 07:52 PM
Glenn Gregory M	President, R&D	Jul 15	Sale	179.45	5,654	1,014,597	2,811	Jul 19 07:52 PM
Erck Stanley C	President and CEO	Jul 02	Option Exercise	80.66	52,559	4,239,511	73,054	Jul 06 05:03 PM
Erck Stanley C	President and CEO	Jul 02	Sale	215.89	52,559	11,347,066	20,495	Jul 06 05:03 PM
Erck Stanley C	President and CEO	Jul 01	Option Exercise	61.59	52,620	3,240,965	73,115	Jul 06 05:03 PM
Erck Stanley C	President and CEO	Jul 01	Sale	212.88	52,620	11,201,513	20,495	Jul 06 05:03 PM
Glenn Gregory M	President, R&D	Jun 17	Sale	183.28	2,411	441,887	2,811	Jun 17 06:17 PM
Glenn Gregory M	President, R&D	Jun 15	Option Exercise	13.16	10,535	138,685	8,527	Jun 17 06:17 PM
Glenn Gregory M	President, R&D	Jun 15	Sale	191.42	5,716	1,094,130	2,811	Jun 17 06:17 PM
EVANS GARY C	Director	Jun 01	Sale	146.50	625	91,562	0	Jun 03 05:34 PM
Herrmann John A III	EVP, Chief Legal Officer	May 28	Option Exercise	14.83	2,895	42,932	3,170	Jun 02 04:59 PM
Herrmann John A III	EVP, Chief Legal Officer	May 28	Sale	149.14	2,895	431,748	275	Jun 02 04:59 PM
King Rachel K.	Director	May 19	Buy	139.64	700	97,748	2,800	May 21 05:06 PM
Glenn Gregory M	President, R&D	May 19	Sale	142.17	2,385	339,066	2,811	May 19 05:26 PM
Glenn Gregory M	President, R&D	May 17	Option Exercise	13.16	10,531	138,577	8,523	May 19 05:26 PM
Glenn Gregory M	President, R&D	May 17	Sale	133.98	5,712	765,267	2,811	May 19 05:26 PM
Trizzino John	EVP, CCO, CBO & Interim CFO	May 07	Sale	176.63	190	33,559	287	May 07 05:10 PM
Trizzino John	EVP, CCO, CBO & Interim CFO	May 05	Option Exercise	14.73	3,406	50,160	3,309	May 07 05:10 PM
Trizzino John	EVP, CCO, CBO & Interim CFO	May 05	Sale	185.46	3,022	560,471	287	May 07 05:10 PM
Herrmann John A III	EVP, Chief Legal Officer	Apr 30	Option Exercise	14.82	2,895	42,892	3,170	May 04 06:03 PM
Herrmann John A III	EVP, Chief Legal Officer	Apr 30	Sale	239.83	2,895	694,317	275	May 04 06:03 PM
Trizzino John	EVP, Chief Commercial Officer	Apr 07	Sale	178.03	191	34,004	287	Apr 07 05:09 PM
Trizzino John	EVP, Chief Commercial Officer	Apr 05	Option Exercise	34.01	3,404	115,771	3,308	Apr 07 05:09 PM
Trizzino John	EVP, Chief Commercial Officer	Apr 05	Sale	190.10	3,021	574,292	287	Apr 07 05:09 PM
Herrmann John A III	EVP, Chief Legal Officer	Mar 26	Option Exercise	14.82	2,894	42,886	3,169	Mar 30 06:10 PM
Herrmann John A III	EVP, Chief Legal Officer	Mar 26	Sale	186.80	2,894	540,609	275	Mar 30 06:10 PM
YOUNG JAMES F	Director	Mar 25	Option Exercise	8.96	47,500	425,438	57,500	Mar 25 06:41 PM
YOUNG JAMES F	Director	Mar 23	Option Exercise	46.00	10,000	460,000	20,000	Mar 25 06:41 PM
YOUNG JAMES F	Director	Mar 23	Sale	228.22	10,000	2,282,231	10,000	Mar 25 06:41 PM
MCMANUS MICHAEL A JR	Director	Mar 19	Sale	220.78	4,000	883,110	5,951	Mar 23 05:33 PM
Glenn Gregory M	President, R&D	Mar 17	Sale	218.86	2,423	530,304	2,811	Mar 17 06:35 PM
Glenn Gregory M	President, R&D	Mar 15	Option Exercise	109.95	10,531	1,157,843	8,523	Mar 17 06:35 PM
EVANS GARY C	Director	Mar 15	Option Exercise	19.52	24,500	478,330	40,599	Mar 17 06:36 PM
EVANS GARY C	Director	Mar 15	Sale	211.21	24,500	5,174,536	16,099	Mar 17 06:36 PM
Glenn Gregory M	President, R&D	Mar 15	Sale	198.60	5,712	1,134,400	2,811	Mar 17 06:35 PM
Trizzino John	EVP, Chief Commercial Officer	Mar 09	Sale	168.09	190	31,937	287	Mar 09 07:38 PM
Trizzino John	EVP, Chief Commercial Officer	Mar 05	Option Exercise	14.73	3,404	50,148	3,308	Mar 09 07:38 PM
Trizzino John	EVP, Chief Commercial Officer	Mar 05	Sale	163.46	3,021	493,824	287	Mar 09 07:38 PM
Herrmann John A III	EVP, Chief Legal Officer	Feb 26	Option Exercise	14.82	2,895	42,892	3,170	Mar 02 05:37 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience